Literature DB >> 28130542

Optimization and Validation of High-Resolution Mass Spectrometry Data Analysis Parameters.

Jennifer M Colby1, Katie L Thoren2, Kara L Lynch3.   

Abstract

High-resolution mass spectrometry (HRMS) has gained recognition as a valuable tool for comprehensive drug screening in a variety of biological matrices. HRMS instruments collect untargeted, accurate mass data, which permit identification of known and unknown compounds in a single analytical run. One of the most challenging aspects of implementing an HRMS drug screen is establishing appropriate data analysis parameters for identifying compounds. Unlike other types of mass spectrometry data, guidelines for HRMS data analysis and acceptability criteria have not been established. Although many laboratories have published on the utility of HRMS for drug screening, few have included details on how they determined allowable errors and set positivity criteria. Previously, we developed and validated a comprehensive 169-compound drug screen on a high-resolution quadrupole time of flight mass spectrometer. Here we report the detailed procedure that we used to determine appropriate positivity criteria for our screening procedure. Our approach was empirical; we collected data and analyzed it with commonly available software. We found that a combined scoring approach using a threshold of 70, with 70% weight given to library match and 10% weight given to each of mass error, retention time error and isotope pattern difference provided optimum drug identification efficiency of 99.2%. Our results demonstrate the importance of library matching in accurately identifying compounds, and underscore the utility of robust product ion spectra that contain information on the lineage, mass and relative abundance of fragments. The method we describe is easily adaptable to include alternative parameters that may be available in software associated with a variety of HRMS platforms. With careful selection of error limits and positivity criteria, HRMS instruments are capable of producing high-quality, high-confidence results that may reduce the need for confirmatory testing.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28130542     DOI: 10.1093/jat/bkw112

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  5 in total

Review 1.  Interpol review of toxicology 2016-2019.

Authors:  Wing-Sum Chan; George Fai Wong; Chi-Wai Hung; Yau-Nga Wong; Kit-Mai Fung; Wai-Kit Lee; Kwok-Leung Dao; Chung-Wing Leung; Kam-Moon Lo; Wing-Man Lee; Bobbie Kwok-Keung Cheung
Journal:  Forensic Sci Int       Date:  2020-05-23       Impact factor: 2.395

Review 2.  Analytical Evaluation of Carbamate and Organophosphate Pesticides in Human and Environmental Matrices: A Review.

Authors:  Nonkululeko Landy Mdeni; Abiodun Olagoke Adeniji; Anthony Ifeanyi Okoh; Omobola Oluranti Okoh
Journal:  Molecules       Date:  2022-01-18       Impact factor: 4.411

3.  Augmentation of MS/MS Libraries with Spectral Interpolation for Improved Identification.

Authors:  Ethan King; Richard Overstreet; Julia Nguyen; Danielle Ciesielski
Journal:  J Chem Inf Model       Date:  2022-07-29       Impact factor: 6.162

4.  Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serum.

Authors:  Yu Zhang; John C Halifax; Christina Tangsombatvisit; Cassandra Yun; Shaokun Pang; Shirin Hooshfar; Alan H B Wu; Kara L Lynch
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2022-07-22

5.  A case of unexplained duodenal ulcer and massive gastrointestinal bleed.

Authors:  Yiqi Ruben Luo; Robert Goodnough; Rebecca Menza; Adina Badea; Hubert Yiu-Wei Luu; Lucy Z Kornblith; Kara L Lynch
Journal:  Clin Chim Acta       Date:  2020-03-29       Impact factor: 6.314

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.